ENSC: 92% | Ensysce Biosciences Reports Completion Of A Constructive End Of Phase 2 Meeting With FDA Regarding Its Lead 'Next Generation' Analgesic, PF614; Phase 3 Program Expected To Begin Enrollment In Mid-2024
PARA: 25% | 'Allen Media Group Makes $14.3 Billion Offer For Paramount Global' - Wall Steet Journal
AMSC: -15% | AMSC shares are trading lower after the company announced a proposed public offering of common stock.